loadpatents
name:-0.007957935333252
name:-0.0021710395812988
name:-0.0039839744567871
TRAUTWEIN; Mark Patent Filings

TRAUTWEIN; Mark

Patent Applications and Registrations

Patent applications and USPTO patent grants for TRAUTWEIN; Mark.The latest application filed is for "pharmaceutical combination of anti ceacam6 and tim3 antibodies".

Company Profile
5.11.24
  • TRAUTWEIN; Mark - Wulfrath DE
  • Trautwein; Mark - Whippany NJ
  • Trautwein; Mark - Wuppertal DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical Combination Of Anti Ceacam6 And Tim3 Antibodies
App 20220089721 - WILLUDA; Jrog ;   et al.
2022-03-24
Pharmaceutical Combination Of Anti-ceacam6 And Either Anti-pd-1 Or Anti-pd-l1 Antibodies For The Treatment Of Cancer
App 20220010017 - WILLUDA; Jorg ;   et al.
2022-01-13
Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodies
Grant 11,071,788 - Lerchen , et al. July 27, 2
2021-07-27
Anti-ceacam6 Antibodies And Uses Thereof
App 20200181261 - WILLUDA; Jorg ;   et al.
2020-06-11
Anti-ceacam6 Antibodies And Uses Thereof
App 20200157214 - WILLUDA; Jorg ;   et al.
2020-05-21
Antibody Drug Conjugates Of Kinesin Spindel Protein (ksp) Inhibitors With Antib7h3-antibodies
App 20200138970 - LERCHEN; Hans-Georg ;   et al.
2020-05-07
Anti-CEACAM6 antibodies and uses thereof
Grant 10,584,167 - Willuda , et al.
2020-03-10
Radio-pharmaceutical Complexes
App 20190298865 - CUTHBERTSON; Alan ;   et al.
2019-10-03
Anti-ceacam6 Antibodies And Uses Thereof
App 20180162940 - WILLUDA; Jorg ;   et al.
2018-06-14
Neutralizing prolactin receptor antibody Mat3 and its therapeutic use
Grant 9,777,063 - Freiberg , et al. October 3, 2
2017-10-03
Neutralizing prolactin receptor antibodies and their therapeutic use
Grant 9,649,374 - Otto , et al. May 16, 2
2017-05-16
Neutralizing Prolactin Receptor Antibody Mat3 And Its Therapeutic Use
App 20160319029 - FREIBERG; Christoph ;   et al.
2016-11-03
Relaxin fusion polypeptides and uses thereof
Grant 9,382,305 - Wilmen , et al. July 5, 2
2016-07-05
Neutralizing prolactin receptor antibody Mat3 and its therapeutic use
Grant 9,353,186 - Freiberg , et al. May 31, 2
2016-05-31
Neutralizing prolactin receptor antibodies and their therapeutic use
Grant 9,241,989 - Otto , et al. January 26, 2
2016-01-26
Pdgfrbeta-fc Fusion Proteins And Uses Thereof
App 20160009776 - Linden; Lars ;   et al.
2016-01-14
Anti-FGFR2 Antibodies and Uses Thereof
App 20140322220 - Harrenga; Axel ;   et al.
2014-10-30
Relaxin Fusion Polypeptides And Uses Thereof
App 20140187491 - Wilmen; Andreas ;   et al.
2014-07-03
Neutralizing Prolactin Receptor Antibody Mat3 And Its Therapeutic Use
App 20140141003 - Freiberg; Christoph ;   et al.
2014-05-22
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use
App 20130272968 - Otto; Christiane ;   et al.
2013-10-17
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use
App 20130171147 - Otto; Christiane ;   et al.
2013-07-04
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use
App 20130129739 - Ottto; Christiane ;   et al.
2013-05-23
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use
App 20130022606 - Otto; Christiane ;   et al.
2013-01-24
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use
App 20120321632 - Otto; Christiane ;   et al.
2012-12-20
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use
App 20120315276 - Otto; Christiane ;   et al.
2012-12-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed